ANTIHYPERTENSIVE AND HORMONAL EFFECTS OF SINGLE ORAL DOSES OF CAPTOPRIL AND NIFEDIPINE IN ESSENTIAL-HYPERTENSION
dc.contributor.author | SOTO, ME | |
dc.contributor.author | THIBONNIER, M | |
dc.contributor.author | SIRE, O | |
dc.contributor.author | MENARD, J | |
dc.contributor.author | CORVOL, P | |
dc.contributor.author | MILLIEZ, P | |
dc.date.accessioned | 2025-01-23T19:44:12Z | |
dc.date.available | 2025-01-23T19:44:12Z | |
dc.date.issued | 1981 | |
dc.description.abstract | In a single-dose crossover study captopril (SQ 14225), 1 mg/kg body wt, and nifedipine (Bay-a 1040) 20 mg were administered orally to 12 hospitalized patients with essential hypertension (stage 1 or 2, WHO). Both drugs significantly reduced blood pressure, but each dose acted differently: the mean maximum arterial pressure reduction was faster and greater with nifedipine than with captopril: -23 .+-. 2% at 37 .+-. 15 min and -17 .+-. 1% at 86 .+-. 25 min, respectively. Captopril inhibited angiotensin II and aldosterone production, but did not accelerate heart rate or stimulate vasopressin release. Nifedipine stimulated vasopressin release and increased heart rate, but the renin-angiotensin-aldosterone system was not significantly affected. The blood pressure reduction was related to the initial level of activation of the renin-angiotensin system only for captopril. The blood pressure reduction induced by 1 drug was not related to that produced by the other in the same patient. | |
dc.fuente.origen | WOS | |
dc.identifier.eissn | 1432-1041 | |
dc.identifier.issn | 0031-6970 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/99975 | |
dc.identifier.wosid | WOS:A1981ME27600001 | |
dc.issue.numero | 3 | |
dc.language.iso | en | |
dc.pagina.final | 161 | |
dc.pagina.inicio | 157 | |
dc.revista | European journal of clinical pharmacology | |
dc.rights | acceso restringido | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | ANTIHYPERTENSIVE AND HORMONAL EFFECTS OF SINGLE ORAL DOSES OF CAPTOPRIL AND NIFEDIPINE IN ESSENTIAL-HYPERTENSION | |
dc.type | artículo | |
dc.volumen | 20 | |
sipa.index | WOS | |
sipa.trazabilidad | WOS;2025-01-12 |